Does TOFACITINIB Cause Red blood cell count decreased? 317 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 317 reports of Red blood cell count decreased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
317
Reports of Red blood cell count decreased with TOFACITINIB
0.2%
of all TOFACITINIB reports
23
Deaths
112
Hospitalizations
How Dangerous Is Red blood cell count decreased From TOFACITINIB?
Of the 317 reports, 23 (7.3%) resulted in death, 112 (35.3%) required hospitalization, and 21 (6.6%) were considered life-threatening.
Is Red blood cell count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 317 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Red blood cell count decreased?
LENALIDOMIDE (1,946)
PALBOCICLIB (1,800)
NIRAPARIB (1,351)
CLOZAPINE (1,075)
RUXOLITINIB (962)
RIBAVIRIN (691)
ADALIMUMAB (639)
PEGINTERFERON ALFA-2A (579)
VENETOCLAX (498)
METHOTREXATE (469)
Which TOFACITINIB Alternatives Have Lower Red blood cell count decreased Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN